BIBLIOGRAPHY
Journal articles:
1.    Zou, X., Li, H., Wang, S., Leski, M., Yao, Y., Yang, X., Huang, Q., and Chen, G-Q.  
3-Hydroxybutyrate methyl ester improves learning and memory in mice. In press.
2.    Leski, M. L., McPhie, D., Hassinger, L. C., Rohowsky, N. and Neve, R.  Mitochondrial Vacuolization
is a Rapid Event following AMPA Receptor Activation.  In Press.
3.    Cheng, S., Chen, G. Q., Leski, M., Zou, B., Wang, Y. and Wu, Q. 2006. The effect of
D,L-beta-hydroxybutyric acid on cell death and proliferation in L929 cells. Biomaterials 27:3758-65.
4.    Cheng, S., Wu, Q., Yang, F., Xu, M., Leski, M. and Chen, G. Q. 2005. Influence of
DL-beta-hydroxybutyric acid on cell proliferation and calcium influx. Biomacromolecules 6:593-7.
5.    Luo, M. H., Leski, M. L. and Andreadis, A. 2004. Tau isoforms which contain the domain encoded by
exon 6 and their role in neurite elongation. J Cell Biochem 91:880-95.
6.    Leski, M. L., Hassinger, L. C., Valentine, S. L., Baer, J. D. and Coyle, J. T. 2002. L-type calcium
channels reduce ROS generation in cerebellar granule cells following kainate exposure. Synapse 43:30-41.
7.    Leski, M. L., Bao, F., Wu, L., Qian, H., Sun, D. and Liu, D. 2001. Protein and DNA oxidation in
spinal injury: Neurofilaments--an oxidation target. Free Rad Biol Med 30:613-24.
8.    Leski, M. L., Valentine, S. L., Baer, J. D. and Coyle, J. T. 2000. Insulin-like growth factor I prevents
the development of sensitivity to kainate neurotoxicity in cerebellar granule cells. J Neurochem 75:1548-56.
9.    Leski, M. L., Valentine, S. L. and Coyle, J. T. 1999. L-type voltage-gated calcium channels modulate
kainic acid neurotoxicity in cerebellar granule cells. Brain Res 828:27-40.
10.  Leski, M. L. and Steward, O. 1996. Protein synthesis within dendrites: Ionic and neurotransmitter
modulation of synthesis of particular polypeptides characterized by gel electrophoresis. Neurochem Res
21:681-90.
11.  Ballestero, R. P., Wilmot, G. R., Leski, M. L., Uhler, M. D. and Agranoff, B. W. 1995. Isolation of
cDNA clones encoding RICH: A protein induced during goldfish optic nerve regeneration with homology to
mammalian 2',3'-cyclic-nucleotide 3'-phosphodiesterases. Proc Natl Acad Sci U S A 92:8621-5.
12.  Leski, M. L. and Agranoff, B. W. 1994. Purification and characterization of p68/70,
regeneration-associated proteins from goldfish brain. J Neurochem 62:1182-91.
13.  Marcotte, P. A., Dudlak, D., Leski, M., Ryan, J. and Henkin, J. 1992. Characterization of a
metalloprotease which cleaves with high site-specificity the Glu(143)-Leu(144) bond of urokinase.
Fibrinolysis 6 (Sup. 1):57-62.
14.  Barnathan, E. S., Kuo, A., Rosenfeld, L., Kariko, K., Leski, M., Robbiati, F., Nolli, M. L., Henkin, J.
and Cines, D. B. 1990. Interaction of single-chain urokinase-type plasminogen activator with human
endothelial cells. J Biol Chem 265:2865-72.
15.  Badylak, S. F., Voytik, S., Klabunde, R. E., Henkin, J. and Leski, M. 1988. Bolus dose response
characteristics of single chain urokinase plasminogen activator and tissue plasminogen activator in a dog
model of arterial thrombosis. Thromb Res 52:295-312.
16.  Valdes, J., Bukofzer, S., Eiznhamer, D. A., Xu, Z.-Q., Jenta, T. R. J., Leski, M. L. and Flavin, M. T.  
A Phase 2 Comparative Study of the Safety & Efficacy of Three Oral Doses of Cethromycin for the
Treatment of Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB).  Prepared for submission.
17.  Bukofzer, S., Gu, Y., Eiznhamer, D. A., Xu, Z.-Q., Jenta, T. R. J., Leski, M. L. and Flavin, M. T.  A
Phase 3 Comparative Study of Cethromycin 150 mg QD and Levofloxacin 500 mg QD for the Treatment of
Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB). Prepared for submission.
18.  Valdes, J., Bukofzer, S., Gu, Y., Eiznhamer, D. A., Xu, Z.-Q., Jenta, T. R. J., Leski, M. L. and Flavin,
M. T.  A Phase 2 Comparative Study of the Safety & Efficacy of Three Oral Doses of Cethromycin for the
Treatment of Acute Bacterial Sinusitis (ABS). Prepared for submission.
19.  Bukofzer, S., Gu, Y., Eiznhamer, D. A., Xu, Z.-Q., Jenta, T. R. J., Leski, M. L. and Flavin, M. T.  A
Phase 2/3 Comparative Study of the Safety & Efficacy of Cethromycin 150 mg QD vs. Cethromycin 150
mg BID for the Treatment of Acute Bacterial Sinusitis (ABS). Prepared for submission.
20.  Bukofzer, S., Gu, Y., Eiznhamer, D. A., Xu, Z.-Q., Jenta, T. R. J., Leski, M. L. and Flavin, M. T.  
Two Phase 3 Comparative Studies of the Safety & Efficacy of Cethromycin 150 mg QD and Penicillin V
500 mg TID for the Treatment of Streptococcal Pharyngitis/Tonsillitis. Prepared for submission.
21.  Bukofzer, S., Valdes, J., Eiznhamer, D. A., Xu, Z.-Q., Jenta, T. R. J., Leski, M. L. and Flavin, M. T.  
A Phase 2 Comparative Study of the Safety & Efficacy of Two Oral Doses of Cethromycin for the
Treatment of Community Acquired Pneumonia (CAP). Prepared for submission.
22.  Bukofzer, S., Gu, Y., Eiznhamer, D. A., Xu, Z.-Q., Jenta, T. R. J., Leski, M. L. and Flavin, M. T.  A
Phase 2/3 Comparative Study of the Safety & Efficacy of Two Oral Doses of Cethromycin for the
Treatment of Community Acquired Pneumonia (CAP). Prepared for submission.
23.  Leski, M. L., Eiznhamer, D. A., Sivko, G., Xu, Z.-Q., Gebhardt, K., Olson, P., Hunt, R. and Flavin,
M. T.  Pharmacokinetics and Efficacy of Cethromycin against a Lethal Inhalational Anthrax Challenge in
Rhesus Macaques. Prepared for submission.


Book Chapters:
1.    Coyle, J.T., Leski, M.L. and Morrison, J.H.: The diverse roles of L-glutamic acid in brain signal
transduction. In: Neuropsychopharmacology, The Fifth Generation of Progress. Kenneth L. Davis, Dennis
Charney, Joseph T. Coyle and Charles Nemeroff, Eds. Lippincott, Williams & Wilkins, Philadelphia, PA.
2002.
Writing Service Home